With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...

Reactions from Apollo, Blackstone, The Carlyle Group and Hamilton Lane on Trump's executive order allowing 401(k) investors ...

In Q2 2025, the global pharma sector experienced a decline in M&A activity, with deals worth $32.9 billion, down 11.6% from Q1. Deal volume fell 12.8% to 130. Oncology led with 51 deals. Discover key ...